EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predicted STAT1-BRAF and IRF7-MET Regulatory Links Are Associated with MAPK Pathway Reactivation and Targeted Therapy Resistance in Melanoma

Hao Fu iD, Mengyao Wang, Haibo Zhu, Weihua Li, Xiaopei Shen iD, Haidan Yan, Jun He iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27188031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Hao Fu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioinformatics, Fujian Key Laboratory of Medical Bioinformatics, Institute of Precision Medicine, School of Medical Technology and Engi…. Hauptthemen laut MEDLINE: Melanoma, Proto-Oncogene Proteins B-raf, Drug Resistance, Neoplasm, STAT1 Transcription Factor. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fujian Science and Technology Innovation Joint Fund Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Resistance to BRAF inhibitors (BRAFi), alone or with MEK inhibitors (MEKi), limits durable responses in BRAF-mutant melanoma. To characterize resistance-associated cell-state evolution, we analyzed 674 melanoma cells from six mice bearing tumors from a single patient-derived BRAF V600E-mutant melanoma xenograft (PDX) lineage before treatment, during initial regression, at minimal residual disease, and at resistant regrowth. Unsupervised clustering based on a BRAF-centered network feature set comprising 2506 candidate genes identified six transcriptional states, which were characterized using transcriptomic analyses. Cluster 4 was detected exclusively at resistant regrowth, a phase marked by MAPK pathway reactivation, and exhibited enhanced JAK-STAT/interferon signaling and increased STAT1, STAT2, IRF7, IRF9, and RELB regulon activities. Network inference predicted STAT1-BRAF and IRF7-MET regulatory links, suggesting candidate routes to MAPK reactivation through BRAF overexpression and MET-mediated bypass signaling. External analyses partially recapitulated the resistance-associated transcriptional program in independent melanoma cell-line datasets and yielded limited, inconclusive evidence for the predicted STAT1-BRAF association in public perturbation datasets. Cluster 2 represented a pre-existing proliferative state whose signature was associated with shorter progression-free survival in pretreatment clinical cohorts. Together, these findings distinguish a therapy-associated acquired-resistance state from a pre-existing proliferative resistance-associated state and nominate the predicted STAT1-BRAF and IRF7-MET links for functional validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaProto-Oncogene Proteins B-rafDrug Resistance, NeoplasmSTAT1 Transcription FactorInterferon Regulatory Factor-7MAP Kinase Signaling SystemAnimalsHumansMiceGene Expression Regulation, NeoplasticCell Line, TumorProtein Kinase Inhibitors

Stichwörter der Autor:innen

BRAF inhibitorIRF7MAPK pathway reactivationMETSTAT1acquired resistancemelanomasingle-cell RNA sequencing

Substanzen

Proto-Oncogene Proteins B-rafSTAT1 Transcription FactorInterferon Regulatory Factor-7BRAF protein, humanSTAT1 protein, humanIRF7 protein, humanProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Bioinformatics, Fujian Key Laboratory of Medical Bioinformatics, Institute of Precision Medicine, School of Medical Technology and Engineering, Fujian Medical University, Fuzhou 350122, China.
  • Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou 350122, China.

ORCID-Profile: Hao Fu, Xiaopei Shen, Jun He

Förderung

  • Fujian Science and Technology Innovation Joint Fund Project

Zitieren

APA

Fu, H., Wang, M., Zhu, H., Li, W., Shen, X., Yan, H., & He, J. (2026). Predicted STAT1-BRAF and IRF7-MET Regulatory Links Are Associated with MAPK Pathway Reactivation and Targeted Therapy Resistance in Melanoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27188031

Vancouver

Fu H, Wang M, Zhu H, Li W, Shen X, Yan H, et al. Predicted STAT1-BRAF and IRF7-MET Regulatory Links Are Associated with MAPK Pathway Reactivation and Targeted Therapy Resistance in Melanoma. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27188031

BibTeX
@article{Fu2026,
  author = {Fu, Hao and Wang, Mengyao and Zhu, Haibo and Li, Weihua and Shen, Xiaopei and Yan, Haidan and He, Jun},
  title = {Predicted STAT1-BRAF and IRF7-MET Regulatory Links Are Associated with MAPK Pathway Reactivation and Targeted Therapy Resistance in Melanoma},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27188031}
}
Kostenlos starten →